Group 1 - The stock of Saikexide (688338.SH) closed at 32.55 yuan, with a decline of 2.11%, currently in a state of breaking issue [1] - Saikexide was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on August 6, 2020, with an initial issuance of 20.41 million shares at a price of 50.35 yuan per share [1] - On its first trading day, Saikexide opened at 180.00 yuan and closed at 170.18 yuan, reaching an intraday high of 186.00 yuan, which remains the highest price since its listing [1] - The total amount of funds raised by Saikexide was 1.028 billion yuan, with a net amount of 924 million yuan after deducting issuance costs, exceeding the original plan by 554 million yuan [1] - The company planned to raise 371 million yuan for projects including production base construction, R&D center construction, marketing network construction, and working capital supplementation [1] - The sponsor institution for Saikexide is China International Capital Corporation (CICC), with representatives Fang Liangrun and Xu Shiyan [1] - The total issuance cost for the initial public offering was 103 million yuan, with CICC receiving 85.322 million yuan in sponsorship and underwriting fees [1] Group 2 - The wholly-owned subsidiary of the sponsor institution, China CICC Wealth Securities Co., Ltd., was allocated 816,480 shares, amounting to 41,109,768 yuan, accounting for 4% of the total shares issued [2] - The lock-up period for the allocated shares is 24 months from the date of listing on the Shanghai Stock Exchange [2] - On July 1, 2023, Saikexide announced its 2022 annual equity distribution plan, which includes a cash dividend of 0.26 yuan per share (tax included) and a capital reserve increase of 0.3 shares per share for all shareholders [2] - The record date for the equity distribution is July 6, 2023, and the ex-dividend date is July 7, 2023 [2]
赛科希德跌2.11% 2020上市即巅峰超募5.5亿